All Stories

  1. Male- and Female-Specific Reproductive Risk Factors Across the Lifespan for Dementia or Cognitive Decline: A Systematic Review and Meta-Analysis (P2-3.006)
  2. Interactions between mild depressive symptoms and amyloid pathology on the trajectory of neurodegeneration, cognitive decline, and risk of Alzheimer's disease
  3. Systolic blood pressure variability in late-life predicts cognitive trajectory and risk of Alzheimer’s disease
  4. Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer’s Disease: A Longitudinal Study
  5. Predicting Cognitive Decline for Non-Demented Adults with High Burden of Tau Pathology, Independent of Amyloid Status
  6. Predicting the reversion from mild cognitive impairment to normal cognition based on magnetic resonance imaging, clinical, and neuropsychological examinations
  7. Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer's Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults
  8. Relationships of Hypnotics with Incident Dementia and Alzheimer's Disease: A Longitudinal Study and Meta-Analysis
  9. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer’s Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population
  10. Male- and female-specific reproductive risk factors across the lifespan for dementia or cognitive decline: a systematic review and meta-analysis
  11. Adult Renal Dysfunction and Risk of Dementia or Cognitive Decline: Brain-Kidney Axis Hypothesis Based on a Systematic Review and Meta-Analysis
  12. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers
  13. Dietary Components and Nutritional Strategies for Dementia Prevention in the Elderly
  14. Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria
  15. Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants
  16. Multi-Concept Frailty Predicts the Late-Life Occurrence of Cognitive Decline or Dementia: An Updated Systematic Review and Meta-Analysis of Longitudinal Studies
  17. A gene–environment interplay between omega‐3 supplementation and APOE ε4 provides insights for Alzheimer’s disease precise prevention amongst high‐genetic‐risk population
  18. Neuroinflammation modulates the association of PGRN with cerebral amyloid-β burden
  19. Insomnia Moderates the Relationship Between Amyloid-β and Cognitive Decline in Late-Life Adults without Dementia
  20. The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers
  21. Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia
  22. Association of Alzheimer’s disease risk variants on the PICALM gene with PICALM expression, core biomarkers, and feature neurodegeneration
  23. Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis
  24. The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases
  25. Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults
  26. Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
  27. Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study
  28. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis
  29. Plasma neurofilament light as a longitudinal biomarker of neurodegeneration in Alzheimer’s disease
  30. Age-related hearing loss accelerates cerebrospinal fluid tau levels and brain atrophy: a longitudinal study
  31. Evidence-Based Prevention of Alzheimer's Disease: Systematic Review and Meta-Analysis of 243 Observational Prospective Studies and 153 Randomized Controlled Trials
  32. The construction of evidence-based profile for Alzheimer’s prevention: a meta-analysis and systematic review assessing the current evidence based on prospective observational studies and randomized controlled trials (P6.183)
  33. Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies
  34. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies (P3.094)
  35. Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies
  36. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum
  37. Meta-Analysis of Modifiable Risk Factors for Alzheimer’s Disease (P1.096)
  38. Meta-analysis of modifiable risk factors for Alzheimer's disease
  39. Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies
  40. The link between the SNCA gene and parkinsonism
  41. The Role of PICALM in Alzheimer’s Disease
  42. Cognitive Reserve and Alzheimer’s Disease